SEQUENT SCIENTIFIC
Back to Balance Sheet
|
SEQUENT SCIENTIFIC Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹122 Cr | ₹176 Cr | ₹209 Cr | ₹154 Cr | ₹216 Cr |
What is the latest Total Non-Current Liabilities ratio of SEQUENT SCIENTIFIC ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹122 Cr |
Mar2023 | ₹176 Cr |
Mar2022 | ₹209 Cr |
Mar2021 | ₹154 Cr |
Mar2020 | ₹216 Cr |
How is Total Non-Current Liabilities of SEQUENT SCIENTIFIC Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹122 Cr | -30.56 | |
Mar2023 | ₹176 Cr | -15.92 | |
Mar2022 | ₹209 Cr | 36.16 | |
Mar2021 | ₹154 Cr | -29.05 | |
Mar2020 | ₹216 Cr | - |
Compare Total Non-Current Liabilities of peers of SEQUENT SCIENTIFIC
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SEQUENT SCIENTIFIC | ₹3,619.3 Cr | 2.2% | -1.3% | 14.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹415,913.0 Cr | 3.4% | 1.7% | 11.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹154,431.0 Cr | 2.7% | -0.3% | 64.1% | Stock Analytics | |
CIPLA | ₹121,021.0 Cr | 3.1% | 2.7% | 0.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹108,050.0 Cr | 3.1% | 6% | 16.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,789.8 Cr | 6% | -2% | -7.6% | Stock Analytics |
SEQUENT SCIENTIFIC Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SEQUENT SCIENTIFIC | 2.2% |
-1.3% |
14.1% |
SENSEX | 1.8% |
-0.9% |
3.7% |
You may also like the below Video Courses